J Korean Soc Geriatr Neurosurg > Volume 20(1); 2024 > Article
Lee, Kim, and Kim: Covered stent placement for the treatment of mycotic extracranial carotid artery aneurysm: a case report and comprehensive review


Extracranial carotid artery aneurysms (ECAAs) are rare, and mycotic aneurysms are even rarer. Here, we report a case of a giant extracranial carotid artery mycotic aneurysm treated successfully with a covered stent. A 78-year-old man with no pertinent medical history other than a history of acute cholangitis 2 months previously presented with a huge expansile, pulsatile, and non-tender mass in the right neck. Cerebral angiography revealed a right ECAA measuring 35.3×27.5 mm involving the bifurcation of the right common carotid artery. Endovascular reconstruction of the right carotid artery using a vascular-covered stent was performed. After treatment, the ECAA was occluded, and the patient had no new neurological symptoms. The patient underwent a concurrent 2-week course of antibiotic therapy, and the masses regressed entirely. Endovascular treatment with a covered stent, along with appropriate antibiotics, is a feasible and safe option for treating mycotic aneurysms involving the carotid bifurcation.


The extracranial carotid artery aneurysm (ECAA) is extremely rare, accounting for 0.4% to 1% of all arterial aneurysms and approximately 4% of peripheral arterial aneurysms [1,2]. Among them, aneurysms caused by infectious etiology called “mycotic aneurysms” are even rarer. The fundamental principles of treating mycotic aneurysms involve a minimum of 6 to 8 weeks of antibiotic therapy and surgical removal or debridement of all infected tissue [3]. The use of medical therapy alone is linked to a 50% mortality rate, prompting most experts to advocate for surgical intervention alongside prolonged antimicrobial therapy [3,4]. Recent research indicates that surgical treatment for mycotic aneurysms is typically avoided due to higher mortality rates and the difficulties in accessing infected tissue [5]. On the contrary, endovascular therapy is gaining more attention due to its lower mortality rates, improved accessibility, and lower risk of hemorrhage from anticoagulation compared with direct surgical repair [5]. We aim to present another successful endovascular treatment (EVT) case of a mycotic aneurysm in the extracranial carotid artery. Our institutional review board approved this study, and the requirement for informed consent was waived (subject number: HC23ZISI0107).

Case Report

A 78-year-old male, who had no previous medical history, was found to have presented with a huge expansile, pulsatile, non-tender mass in the right neck (Fig. 1A, B). He was diagnosed with acute cholangitis based on an abdominal-pelvic enhanced computed tomography (CT) scan and received one week of antibiotic treatment. The patient experienced sore throat symptoms and neck swelling 2 weeks after discharge. Three weeks after discharge, he exhibited generalized weakness and gait instability, fell at home, and presented to the hospital again due to several contusions. He reported persistent dizziness and transient ischemic attack symptoms since discharge, which led to approximately 5 to 6 similar episodes of falling.
CT neck angiography revealed a giant aneurysm at the bifurcation of the right common carotid artery (CCA) (Fig. 1C, D). Magnetic resonance imaging (MRI) revealed delayed perfusion in the right hemisphere (Fig. 1E). Cerebral angiography revealed a right ECAA measuring 35.3×27.5 mm that involved a bifurcation of the right CCA (Fig. 2A, B). On the right CCA angiogram, blood flow to the right external carotid artery (ECA) was not identified, and the right ECA flow was confirmed through collateral flow from the right vertebral artery (Fig. 2C, D). During symptom manifestation, the patient tested positive for Staphylococcus aureus in a blood culture test. Considering its rapid growth, the patient was diagnosed with a mycotic aneurysm. Considering the complexity of surgical access to the infected surrounding tissue, EVT was performed for aneurysms.
Under local anesthesia, right femoral access was obtained using an 80 cm 8 Fr Shuttle sheath (Cook, Bloomington, IN, USA). Control angiography of the right CCA revealed the presence of a right ECAA (Fig. 3A). The right internal carotid artery (ICA) was selectively catheterized beyond the ECAA using a 125 cm 5 Fr Headhunter 1 angiocatheter and a stiff-type 0.035-inch Radifocus guidewire (Terumo), and an 8 Fr Shuttle sheath was placed in the right CCA (Fig. 3B). Subsequently, the guidewire was exchanged with a 0.035-inch 260 cm exchange guidewire (Terumo, Leuven, Belgium) for stent delivery. An 8.0 mm×60 mm Covera Plus vascular-covered stent (Bard, Tempe, AZ, USA) was deployed to cover the entire segment affected by the aneurysm (Fig. 3C). A postoperative control angiogram revealed a complete cessation of blood flow into the aneurysm after deployment of the covered stent (Fig. 3D). The patient did not develop any new neurological complications after the procedure. After the procedure, a dual antiplatelet therapy with aspirin and clopidogrel was administered.
The patient received a concurrent course of antibiotic therapy. Considering the methicillin-resistant Staphylococcus aureus (MRSA) bacteremia confirmed by blood cultures, intravenous vancomycin was administered. After a week of vancomycin treatment, the blood cultures turned negative. Intravenous vancomycin was continued for an additional 2 weeks. Upon discharge, the patient was prescribed a one-week course of empirical levofloxacin 750 mg. After 2 weeks, most pulsatile and expansile masses had improved remarkably (Fig. 4A, B). In addition, there was an improvement in the right cerebral hemisphere’s time to peak delay on the postoperative MRI perfusion compared to the preoperative MRI perfusion (Fig. 4C, D). Also, the patient remained free from any discernible atypical neurological manifestations.


This case report presents a mycotic pseudoaneurysm located at the bifurcation of the right extracranial CCA that was effectively managed using a covered stent. The successful management of this pseudoaneurysm offers evidence to support the viability of EVT as a therapeutic option among the array of treatments available for ECAA.
Mycotic aneurysms are infrequent causes of ECAA and present a clinical challenge in complex and demanding cases. Mycotic aneurysms’ most common causative pathogens are Staphylococcus and Streptococcus species, with diseases such as syphilis, tuberculosis, and untreated infective endocarditis frequently mentioned as the primary underlying conditions [6,7].
The pathophysiology of mycotic aneurysms is the confluence of arterial injury and bacterial seeding, which gives rise to intimal infection [3]. Upon microorganism infiltration into the vessel wall, rapid degradation of the deeper layers ensues, ultimately leading to the genesis of an aneurysm [3]. This pathophysiological mechanism is precisely why the complete removal of infected tissue becomes crucial, and surgical repair becomes the principle of treatment for mycotic aneurysms beyond the scope of antibiotic therapy alone.
However, the conventional approach to surgical repair has recently been less favored due to a higher prevalence of cranial nerve dysfunction and limited accessibility to infected tissue [8,9]. According to Li et al.’s systematic review [9], there is a growing interest in endovascular stenting for ECAA treatment, particularly in cases where the neck presents challenges due to factors like infection or radiation. Compared to surgical procedures, endovascular stenting eliminates the necessity for general anesthesia and enables continuous intraprocedural neurological status monitoring [9]. In practice, endovascular approaches for ECAA are being successfully performed more frequently than in previous years. Baril et al. [10] introduced the possibility of attempting aneurysm treatment through endovascular procedures, particularly in cases where direct surgical repair is challenging due to previous surgical or radiation therapy or anatomical reasons involving the location of the infected field. Bulsara et al. [11] also presented a case of EVT utilizing a covered stent for a pseudoaneurysm of the right ICA that occurred following MRSA infection.
After identifying ECAA, several EVT options were considered. We initially assessed the feasibility of stent-assisted coil embolization and flow diverter stent placement. However, challenges arose due to the large size of the aneurysm, which made appropriately sized devices unavailable for these techniques. Additionally, the unique blood flow characteristics involving the carotid bifurcation raised doubts about the effectiveness of these methods. These concerns led us to opt for an alternative treatment strategy using a covered stent. Covered stent-grafts are generally used for the treatment of aneurysms and pseudoaneurysms in the aorta, iliac arteries, and femoral arteries; however, several successful cases have utilized covered stent-grafts for pseudoaneurysms in the extracranial carotid artery [12,13]. Gupta et al. [14] demonstrated successful aneurysm removal using a covered stent to treat mycotic intracavernous carotid artery aneurysms.
Several precautions must be taken when performing EVT with a covered stent for ECAA mycotic aneurysms. The first point to consider is that there is no established regimen for antiplatelet therapy after covered stent insertion. Lai et al. [15] suggested that irregular post-procedural antiplatelet therapy and cerebrovascular arteriosclerosis are key predictors of in-stent stenosis or occlusion in covered stents used to treat intracranial vascular disease. Furthermore, they advocated the need to maintain dual antiplatelet therapy for a minimum of 6 months or more. Zhu et al. [16] recommended short-term anticoagulant therapy with low molecular weight heparin after stent graft insertion, followed by at least 6 to 12 months of dual antiplatelet therapy. Following stent-assisted coil embolization, dual antiplatelet therapy is commonly maintained for 6 to 12 months. If the aneurysm does not require retreatment and the stent remains intact, transition to a single antiplatelet agent is considered. The second point of consideration is the necessity for follow-up of ECA occlusion. Immediate occlusion of the ECA was observed on angiography after stent insertion. Owing to the application of a graft stent, ECA occlusion is inevitable, and in most cases, the clinical symptoms of ECA occlusion are not prominent. According to Siracuse et al. [17], ECA stenosis occurring after ICA stent placement did not manifest clinically significant symptoms, and they argued that the possibility of ECA stenosis should not deter from including the ECA origin in ICA stent insertion. Casey et al. [18] emphasized that ECA stenosis can occur frequently following carotid endarterectomy and carotid artery stenting, underscoring the need for long-term evaluation. Despite identifying collateral flow via the vertebral artery into the ECA before stent insertion, regular assessments and follow-up studies are advised to monitor any possible neurological symptoms after ECA occlusion. Finally, from a practical standpoint, it is essential to prepare adequately to ensure medical reimbursement. Covered stent-grafts are generally used for the treatment of aneurysms and pseudoaneurysms in the aorta, iliac arteries, and femoral arteries. Therefore, when submitting insurance claims, it is crucial to provide thorough justification for the necessity of using covered stents in the treatment of ECAA. Fortunately, in this case, there were no issues related to insurance coverage.
Consequently, in cases where surgical treatment complications or limited accessibility are prominent, a covered stent with appropriate antibiotics may be a favorable treatment method for mycotic ECAA.


No potential conflict of interest relevant to this article was reported.

Fig. 1.
Gross findings of the anteroposterior (A) and lateral (B) views of the neck. The swelling in the right neck (indicated by a white circle), which is attributed to a right extracranial carotid artery aneurysm (ECAA), is confirmed. (C) Axial computed tomography (CT) angiography image of the right ECAA. (D) A CT maximum intensity projection reconstruction image depicts a large aneurysm in the bifurcation of the right common carotid artery. (E) In perfusion magnetic resonance imaging, a delay in time to peak is observed in the right cerebral hemisphere. Written informed consent was obtained for publication of this case report and accompanying images.
Fig. 2.
Anteroposterior (A) and lateral (B) projections of the preoperative right common carotid artery angiogram demonstrate the presence of a right extracranial carotid artery aneurysm, with the right external carotid artery (ECA) not being opacified. Anteroposterior (C) and lateral (D) projections of the preoperative right vertebral angiogram revealed collateral flow to the right ECA. Written informed consent was obtained for publication of this case report and accompanying images.
Fig. 3.
Preoperative and postoperative angiographic images of the right common carotid artery. (A) A preoperative control angiogram of the right common carotid artery (CCA) revealed the presence of the right extracranial carotid artery aneurysm (ECAA). (B) The right internal carotid artery was selectively catheterized beyond the ECAA using a 125-cm, 5-Fr Headhunter 1 angiocatheter and a stiff-type 0.035-inch Radifocus guide wire, and an 8-Fr Shuttle sheath was placed in the right CCA. (C) An 8.0 mm × 60 mm Covera plus vascular-covered stent was deployed, covering the entire segment affected by the aneurysm. (D) A postoperative control angiogram revealed complete cessation of blood flow into the aneurysm after the deployment of the covered stent. Written informed consent was obtained for publication of this case report and accompanying images.
Fig. 4.
(A) Preoperative and (B) 2-week postoperative gross findings of the right extracranial carotid artery aneurysm. A significant reduction in neck swelling is observed after applying the covered stent. (C) Preoperative and (D) postoperative perfusion magnetic resonance imaging findings demonstrate an improvement in right cerebral hemisphere time to peak delay following the application of the covered stent. Written informed consent was obtained for publication of this case report and accompanying images.


1. Reslan OM, Ebaugh JL, Raffetto JD. Bilateral asymptomatic extracranial carotid artery aneurysms. Ann Vasc Surg 2010;24:691.
2. Garg K, Rockman CB, Lee V, et al. Presentation and management of carotid artery aneurysms and pseudoaneurysms. J Vasc Surg 2012;55:1618-22.
crossref pmid
3. Majeed H, Ahmad F. Mycotic aneurysm. StatPearls. StatPearls Publishing; 2023.
4. Sundarrajan C, Isa SA, Caruso JP, et al. Treatment of large infectious extracranial carotid artery pseudoaneurysms in children: a systematic review of the literature. Childs Nerv Syst 2021;37:1461-70.
crossref pmid pdf
5. Alawieh A, Chaudry MI, Turner RD, Turk AS, Spiotta AM. Infectious intracranial aneurysms: a systematic review of epidemiology, management, and outcomes. J Neurointerv Surg 2018;10:708-16.
crossref pmid
6. Martens S, Beelen R, Degrieck I. Mycotic aneurysm of the extracranial carotid artery: a case report and review of the literature. Acta Chir Belg 2011;111:97-9.
crossref pmid
7. Van Den Berg JC, Engelberger S. Endovascular treatment of extracranial carotid artery aneurysms. J Cardiovasc Surg (Torino) 2015;56:547-57.
8. Welleweerd JC, den Ruijter HM, Nelissen BG, et al. Management of extracranial carotid artery aneurysm. Eur J Vasc Endovasc Surg 2015;50:141-7.
crossref pmid
9. Li Z, Chang G, Yao C, et al. Endovascular stenting of extracranial carotid artery aneurysm: a systematic review. Eur J Vasc Endovasc Surg 2011;42:419-26.
crossref pmid
10. Baril DT, Ellozy SH, Carroccio A, Patel AB, Lookstein RA, Marin ML. Endovascular repair of an infected carotid artery pseudoaneurysm. J Vasc Surg 2004;40:1024-7.
crossref pmid
11. Bulsara KR, Aruny JE, Muhs B. Infectious pseudoaneurysm of the internal carotid artery treated with a covered stent. J Neurointerv Surg 2009;1:51-2.
crossref pmid
12. Layton KF, Kim YW, Hise JH. Use of covered stent grafts in the extracranial carotid artery: report of three patients with follow-up between 8 and 42 months. AJNR Am J Neuroradiol 2004;25:1760-3.
pmid pmc
13. Kim HO, Ji YB, Lee SH, Jung C, Tae K. Cases of common carotid artery pseudoaneurysm treated by stent graft. Case Rep Otolaryngol 2012;2012:674827.
crossref pmid pmc pdf
14. Gupta V, Jain V, Mathuria SN, Khandelwal N. Endovascular treatment of a mycotic intracavernous carotid artery aneurysm using a stent graft. Interv Neuroradiol 2013;19:313-9.
crossref pmid pmc pdf
15. Lai XB, Li MH, Tan HQ, et al. Predictors of in-stent stenosis and occlusion after endovascular treatment of intracranial vascular disease with the Willis covered stent. J Clin Neurosci 2013;20:122-7.
crossref pmid
16. Zhu Y, Tan H, Wu Z, et al. Use of covered stents to treat complex cerebrovascular diseases: expert consensus. Front Cardiovasc Med 2022;9:934496.
crossref pmid pmc
17. Siracuse JJ, Epelboym I, Li B, Hoque R, Catz D, Morrissey NJ. External carotid artery stenosis after internal and common carotid stenting. Ann Vasc Surg 2015;29:443-6.
crossref pmid
18. Casey K, Zhou W, Tedesco MM, Al-Khatib WK, Hernandez-Boussard T, Bech F. Fate of the external carotid artery following carotid interventions. Int J Angiol 2009;18:173-6.
crossref pmid pmc
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 229 View
  • 4 Download

Hooin Lee

Il Jung Kim

Sunghan Kim

Related articles

Editorial Office
21, Namdong-daero 774beon-gil, Namdong-gu, Incheon 21565, Korea
Tel: +82-32-460-3304    Fax: +82-32-460-3899    E-mail: editor@jksgn.org                

Copyright © 2024 by Korean Society of Geriatric Neurosurgery.

Developed in M2PI

Close layer
prev next